Abstract
The therapeutic outcome of cisplatin is limited due to its adverse side effects in normal tissues. Despite its potent antineoplastic effect, cisplatin is known by a relevant collateral action, for instance, acute renal failure. The aim of this study was to assess the effectiveness of Pituranthos chloranthus (PC) essential oil for contracting cisplatin-induced toxicity, in Balb/c mice. The standard mouse model of cisplatin-induced acute kidney injury (AKI), consisting of one intraperitoneal injection of cisplatin (20 mg/kg), was adopted. Mice were pretreated by intraperitoneal administration of PC (5 and 10 mg/Kg b.w) for one week. Cisplatin induced alteration in renal and liver functions, evidenced by increased serum biomarkers levels (creatinine, ALT, and AST). Significant mitigation of cisplatin-induced toxicity was confirmed by lowered levels of serum biomarkers and reduced DNA damage in liver and kidney. PC also restored the alterations in oxidative stress markers and proinflammatory cytokine IFN-γ level. Overall, this study provides, for the first time, that PC can be applied as an antioxidant-adjuvant treatment to mitigate cisplatin-induced renal failure.
References
Jun 1, 1979·Analytical Biochemistry·H OhkawaK Yagi
Jun 1, 1991·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·H MatsumotoI M Shapiro
Mar 1, 1988·Experimental Cell Research·N P SinghE L Schneider
May 1, 1984·Kidney International·R SafirsteinJ B Guttenplan
Jan 27, 2000·Cancer Chemotherapy and Pharmacology·R KröningG T Nagami
Feb 25, 2000·Allergy·G Tau, P Rothman
Oct 2, 2004·BMC Pharmacology·Yolanda I ChirinoJosé Pedraza-Chaverrí
Jul 13, 2007·Nature Reviews. Cancer·Lloyd Kelland
Dec 6, 2008·Letters in Applied Microbiology·T YanguiS Sayadi
Sep 3, 2010·Journal of Nucleic Acids·Alakananda Basu, Soumya Krishnamurthy
Aug 2, 2011·Life Sciences·Wani Arjumand, Sarwat Sultana
Nov 10, 2011·Toxins·Ronald P MillerWilliam Brian Reeves
Jul 13, 2012·Kidney International·Akihiko KimuraToshikazu Kondo
Sep 3, 2013·Antioxidants & Redox Signaling·Manish MittalAsrar B Malik
Jan 1, 2011·Cancers·Ana-Maria Florea, Dietrich Büsselberg
Jul 8, 2014·Oxidative Medicine and Cellular Longevity·Antonio AyalaSandro Argüelles
Jul 25, 2014·European Journal of Pharmacology·Shaloam Dasari, Paul Bernard Tchounwou
Mar 18, 2015·Mutagenesis·Abhishek BasuSudin Bhattacharya
Jun 15, 2016·Peptides·Takashi NojiriKenji Kangawa
Nov 7, 2016·Microbial Pathogenesis·Aida LahmarLeila Chekir-Ghedira
Jan 25, 2017·Journal of Toxicology·Jessica PakenVikash Sewram
Apr 15, 2017·Oncotarget·Reza Bayat MokhtariHerman Yeger
Nov 22, 2017·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Mouna MaatoukLeila Chekir-Ghedira
Mar 3, 2019·Naunyn-Schmiedeberg's Archives of Pharmacology·Filiz MercantepeLevent Tumkaya
Citations
Oct 3, 2020·Life Sciences·Lamiaa A A BarakatSalma M Khirallah
Nov 1, 2020·Biomolecules·Maged E MohamedNancy S Younis
Jun 3, 2021·Antioxidants·Enas E EltamanyAsmaa R Abdel-Hamed